Geode Capital Management, LLC Rocket Pharmaceuticals, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,502,587 shares of RCKT stock, worth $32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,502,587
Previous 1,457,250
3.11%
Holding current value
$32 Million
Previous $43.7 Million
7.31%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding RCKT
# of Institutions
206Shares Held
92.9MCall Options Held
341KPut Options Held
107K-
Rtw Investments, LP New York, NY17.7MShares$377 Million7.65% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$195 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.93MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.37MShares$115 Million0.0% of portfolio
-
State Street Corp Boston, MA4.19MShares$89.4 Million0.01% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.61B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...